Vuslat Yılmaz

1.7k total citations
72 papers, 1.1k citations indexed

About

Vuslat Yılmaz is a scholar working on Neurology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Vuslat Yılmaz has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 17 papers in Infectious Diseases and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Vuslat Yılmaz's work include Myasthenia Gravis and Thymoma (22 papers), Peripheral Neuropathies and Disorders (21 papers) and Multiple Sclerosis Research Studies (13 papers). Vuslat Yılmaz is often cited by papers focused on Myasthenia Gravis and Thymoma (22 papers), Peripheral Neuropathies and Disorders (21 papers) and Multiple Sclerosis Research Studies (13 papers). Vuslat Yılmaz collaborates with scholars based in Türkiye, Hungary and United States. Vuslat Yılmaz's co-authors include Güher Saruhan‐Direskeneli, Sibel P. Yentür, Erdem Tüzün, Feza Deymeer, Yeşim Parman, Piraye Oflazer, Canan Ulusoy, Fikret Aysal, Haner Di̇reskeneli̇ and Angela Vincent and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vuslat Yılmaz

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vuslat Yılmaz Türkiye 20 456 241 191 162 161 72 1.1k
Sibel P. Yentür Türkiye 16 224 0.5× 217 0.9× 108 0.6× 116 0.7× 172 1.1× 31 863
Catherine Keohane Ireland 21 361 0.8× 235 1.0× 199 1.0× 340 2.1× 129 0.8× 64 1.8k
Philipp Schwenkenbecher Germany 21 307 0.7× 117 0.5× 106 0.6× 146 0.9× 159 1.0× 56 902
Élisabeth Maillart France 17 439 1.0× 139 0.6× 86 0.5× 146 0.9× 175 1.1× 100 1.0k
Shanthi Viswanathan Malaysia 14 622 1.4× 198 0.8× 95 0.5× 86 0.5× 206 1.3× 59 1.1k
Anne‐Katrin Pröbstel Switzerland 16 495 1.1× 233 1.0× 114 0.6× 238 1.5× 174 1.1× 32 1.1k
Joerg‐Patrick Stübgen United States 15 291 0.6× 84 0.3× 53 0.3× 115 0.7× 121 0.8× 38 699
Timothy Lotze United States 19 468 1.0× 68 0.3× 147 0.8× 417 2.6× 166 1.0× 63 1.4k
Aslı Kurne Türkiye 18 228 0.5× 119 0.5× 37 0.2× 134 0.8× 124 0.8× 60 746
Michel Toledano United States 17 904 2.0× 99 0.4× 203 1.1× 182 1.1× 54 0.3× 54 1.5k

Countries citing papers authored by Vuslat Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Vuslat Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vuslat Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vuslat Yılmaz more than expected).

Fields of papers citing papers by Vuslat Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vuslat Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vuslat Yılmaz. The network helps show where Vuslat Yılmaz may publish in the future.

Co-authorship network of co-authors of Vuslat Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Vuslat Yılmaz. A scholar is included among the top collaborators of Vuslat Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vuslat Yılmaz. Vuslat Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yılmaz, Vuslat, et al.. (2025). P0385 Delayed Diagnosis in Inflammatory Bowel Disease in Turkish Population. Journal of Crohn s and Colitis. 19(Supplement_1). i873–i874.
3.
Savaş, Merve, Pınar Topaloğlu, Vuslat Yılmaz, et al.. (2024). Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES). Epilepsy & Behavior. 163. 110225–110225.
4.
5.
Tas, A.C., Vuslat Yılmaz, Şaban Teki̇n, et al.. (2023). Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2. International Journal of Molecular Sciences. 24(15). 11957–11957. 1 indexed citations
6.
Gezen‐Ak, Duygu, Erdinç Dursun, Ahmet Tarık Baykal, et al.. (2023). Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement. Multiple Sclerosis and Related Disorders. 78. 104940–104940. 2 indexed citations
7.
Tüzün, Erdem, Arman Çakar, Aysun Soysal, et al.. (2023). Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes. Clinical & Experimental Immunology. 215(1). 65–78. 1 indexed citations
8.
Oswald, Eva, Atay Vural, Vuslat Yılmaz, et al.. (2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(2). 13 indexed citations
9.
Akdeniz, Nilgün, Vuslat Yılmaz, Umut Can Küçüksezer, et al.. (2022). The modulatory action of C-Vx substance on the immune system in COVID-19. Emerging Microbes & Infections. 11(1). 2698–2710. 2 indexed citations
10.
Gezen‐Ak, Duygu, Gülçin Benbir Şenel, Erdinç Dursun, et al.. (2022). Classical complement pathway factor alterations in narcolepsy. Acta Neuropsychiatrica. 34(4). 212–219. 3 indexed citations
11.
Orhun, Günseli, Figen Esen, Vuslat Yılmaz, et al.. (2021). Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy. International Journal of Neuroscience. 133(3). 327–333. 12 indexed citations
12.
Tombul, Temel, et al.. (2021). miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study. Genetic Testing and Molecular Biomarkers. 25(11). 720–726. 12 indexed citations
13.
Yılmaz, Vuslat, et al.. (2021). Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2570–2574. 1 indexed citations
14.
Yılmaz, Vuslat, Canan Ulusoy, Recai Türkoğlu, et al.. (2020). Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis. Immunological Investigations. 50(6). 671–684. 9 indexed citations
15.
16.
Türkoğlu, Recai, et al.. (2019). Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event. International Ophthalmology. 40(1). 151–158. 6 indexed citations
17.
Erdağ, Ece, Cem İ̇smail Küçükali, Murat Kürtüncü, et al.. (2019). Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease. In Vivo. 33(5). 1493–1497. 12 indexed citations
18.
Yılmaz, Vuslat, Piraye Oflazer, Fikret Aysal, et al.. (2014). The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey. PLoS ONE. 9(8). e104760–e104760. 7 indexed citations
19.
Li, Jing, Erdem Tüzün, Vuslat Yılmaz, et al.. (2009). Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis. Journal of Neuroimmunology. 208(1-2). 40–45. 9 indexed citations
20.
Yılmaz, Vuslat, et al.. (2005). Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.. PubMed. 32(1). 93–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sibel P. Yentür Breakdown of academic impact, for papers by Catherine Keohane Breakdown of academic impact, for papers by Philipp Schwenkenbecher Breakdown of academic impact, for papers by Élisabeth Maillart Breakdown of academic impact, for papers by Shanthi Viswanathan Breakdown of academic impact, for papers by Anne‐Katrin Pröbstel Breakdown of academic impact, for papers by Joerg‐Patrick Stübgen Breakdown of academic impact, for papers by Timothy Lotze Breakdown of academic impact, for papers by Aslı Kurne Breakdown of academic impact, for papers by Michel Toledano
Rankless by CCL
2026